Management of Adverse Effects Associated With Novel Therapies Podcast Por  arte de portada

Management of Adverse Effects Associated With Novel Therapies

Management of Adverse Effects Associated With Novel Therapies

Escúchala gratis

Ver detalles del espectáculo
OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.

Management of relapsed/refractory LBCLs remains a substantial and persistent clinical challenge, including optimal treatment sequencing, therapy evaluation and patient selection, and toxicity management.

Todavía no hay opiniones